

KSF and Charles C. Foti Jr. notified ADMA Biologics investors of a class action securities lawsuit. The filing is a negative overhang for sentiment, though the announcement provides no quantified financial impact or specific allegations in the excerpt.
KSF and Charles C. Foti Jr. notified ADMA Biologics investors of a class action securities lawsuit. The filing is a negative overhang for sentiment, though the announcement provides no quantified financial impact or specific allegations in the excerpt.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment